# Protagonist Therapeutics, Inc: Form 8-K, filed Mar 3, 2025

- Company: [Protagonist Therapeutics, Inc](/companies/ptgx.md) (CIK 1377121)
- Form: 8-K
- Filed: 2025-03-03
- Accepted by EDGAR: Mar 3, 2025, 08:18 ET
- Period: 2025-03-03
- Accession: 0001104659-25-019516
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1377121/000110465925019516/tm258056d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1377121/000110465925019516/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1377121/000110465925019516/tm258056d1_8k.htm

Filed Mar 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-019516. Last ingested by Listed: Nov 6, 2026, 12:26 ET. No prices; not investment advice.